Insulin aspart, recombinant Subcutaneous and Tagamet HB
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tagamet HB and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: cimetidine
Brand name: Tagamet HB, Tagamet
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tagraxofusp
- Insulin aspart, recombinant Subcutaneous-Tagraxofusp-erzs
- Insulin aspart, recombinant Subcutaneous-Tagrisso
- Insulin aspart, recombinant Subcutaneous-Take Action
- Insulin aspart, recombinant Subcutaneous-Talacen
- Insulin aspart, recombinant Subcutaneous-Talazoparib
- Tagamet HB-Insulin degludec
- Tagamet HB-Insulin Degludec (U-100) Prefilled Pens
- Tagamet HB-Insulin Degludec (U-100) Vials
- Tagamet HB-Insulin Degludec (U-200) Prefilled Pens
- Tagamet HB-Insulin degludec and liraglutide
- Tagamet HB-Insulin degludec and liraglutide Subcutaneous